| Title |
Multi center, randomized, double-blind, placebo-controlled clinical study on the effect of henagliflozin on aging markers in patients with type 2 diabetes |
| Description |
The aim of this study is to evaluate the effect of henagliflozin on aging biomarkers in patients with type 2 diabetes. During the study, blood samples were collected from the participants. Serum metabolomic changes after intervention were analyzed using LC-MS/MS, along with changes in telomere length, body weight, body fat distribution, glucose and lipid metabolism, and pancreatic function. |
| Organism |
Homo sapiens |
| Data Type |
Lipidome Data by Mass Spectrometry (MS) |
| Data Accessibility |
Controlled-access |
| BioProject |
PRJCA027074 |
| Release Date |
2025-09-10 |
| Submitter |
Jixiong Xu (Jixiong.Xu@ncu.edu.cn) |
| Organization |
the First Affiliated Hospital of Nanchang University |
| Submission Date |
2024-06-15 |